Riskpilot← Back to searchSign inGet full accessNovo Nordisk Denmark A/S
A/SActiveCVR 38180045Kay Fiskers Plads 10Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2016300 employees
Revenue 2024
DKK 2,4B
+17% vs 2023
EBITDA margin
4.8%
+3% vs 2023
Equity ratio
9.6%
Financial strength
Net profit 2024
DKK 86,1M
+5% vs 2023
| Revenue | DKK 2,4B | +17% |
| EBITDA | DKK 113,8M | +3% |
| Net profit | DKK 86,1M | +5% |
| Total assets | DKK 1,1B | -11% |
| Equity | DKK 101,8M | +4% |
| Employees | 300 | — |
Legal name
Novo Nordisk Denmark A/S
CVR number
38180045
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
14. november 2016
Share capital
DKK 500.000
Employees
300 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to bestyrelsesmedlemmer i forening eller af et bestyrelsesmedlem i forening med en direktør
Company purpose
Selskabets formål er at markedsføre, promovere, importere, sælge og distribuere farmaceutiske og medicinske produkter, repræsentation af selskaber, supporterende services og forretningsassistance til interessenter i Europa, rådgivning og services i forbindelse med registrering af farmaceutiske produkter, forskning og udvikling af farmaceutiske produkter, kliniske forsøg, samt anden hertil knyttet virksomhed der ikke er forbudt ved lov. Selskabets formål er tillige at understøtte Novo Nordisk A/S farmaceutiske aktivitet. Selskabet tilstræber at drive sin virksomhed på økonomisk, miljømæssigt og socialt ansvarlig vis.
Address
Kay Fiskers Plads 10
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 317.443 | 341.939 | 363.936 | 330.145 | 373.940 | 509.920 | 2.017.346 | 2.367.751 |
| Staff expenses | -104.660 | -112.888 | -125.899 | -238.729 | -271.820 | -281.181 | -362.697 | -450.591 |
| EBITDA | 6.973 | 6.339 | 8.988 | 37.403 | 40.071 | 51.992 | 110.782 | 113.771 |
| Depreciation & amort. | -85 | -177 | -177 | -9.195 | -9.840 | -9.361 | -9.762 | -12.400 |
| EBIT | 6.888 | 6.162 | 8.811 | 28.208 | 30.232 | 42.630 | 101.020 | 101.371 |
| Net financials | 198 | 87 | -511 | -200 | -1.586 | 1.404 | 6.892 | 14.332 |
| Profit before tax | 7.086 | 6.249 | 8.300 | 28.008 | 28.645 | 44.034 | 107.912 | 115.703 |
| Tax | 1.708 | 2.036 | 3.048 | 6.730 | 7.240 | 10.486 | 25.914 | 29.574 |
| Net profit | 5.379 | 4.213 | 5.252 | 21.278 | 21.405 | 33.548 | 81.998 | 86.129 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 124.799 | 130.040 | 149.608 | 584.971 | 283.420 | 446.734 | 1.184.004 | 1.056.004 |
| Equity | 5.879 | 10.092 | 15.343 | 36.587 | 36.993 | 49.140 | 97.638 | 101.767 |
| Long-term debt | 0 | 0 | 0 | 18.909 | 4.764 | 20.613 | 29.882 | 28.221 |
| Short-term debt | 10.443 | 118.924 | 133.002 | 526.876 | 203.802 | 338.909 | 1.011.587 | 913.534 |
| Total debt | 117.896 | 118.924 | 133.002 | 545.785 | 208.566 | 359.522 | 1.041.468 | 941.755 |
EBITDA margin
4.8%
This company
15.8%
Market median
-70% vs market
20172024
Equity ratio
9.6%
This company
38.2%
Market median
-75% vs market
20172024
Return on equity
84.6%
This company
18.4%
Market median
+360% vs market
20172024
Net profit margin
3.6%
This company
8.1%
Market median
-56% vs market
20172024
Asset turnover
2.24×
This company
1.12×
Market median
+100% vs market
20172024
Debt / equity
9.38×
This company
0.62×
Market median
-1413% vs market
20172024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2016-11-14 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SH Management | Management | 2018 | — | — |
KB Management | Management | 2019 | — | — |
MB Management | Management | 2018 | — | — |
MW Management | Management | 2025 | — | — |
MV Management | Management | 2016 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2026 | — | — | |
| Chairman | 2020 | — | — | |
| Chairman | 2017 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2018 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2016 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2016 | — | — | |
| Chairman | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
NOVO NORDISK REGION EUROPE A/S | Company | 100.0% | 100.0% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Novo Holdings A/SNOVO NORDISK A/SNOVO NORDISK REGION EUROPE A/S
Novo Nordisk Denmark A/S (this company)Board members of Novo Nordisk Denmark A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Steffen Hillebrandt Thejls | Management | 0 companies |
| Kasper Bødker Mejlvang | Management | 0 companies |
| Morten Berger Engelund | Management | 0 companies |
| Mads Wilhelm Øckenholt Larsen | Management | 0 companies |
| Mads Veggerby Lausten | Management | 0 companies |
| Jonas Emil Kongshøj Larsen | Chairman | 0 companies |
| David Marcus Svensson | Board of Directors | 0 companies |
| Frederik Kier | Chairman | 0 companies |
| Ole Falvig Ramsby | Chairman | 0 companies |
| Malin Eva Maria Andreasen | Board of Directors | 0 companies |
| Karsten Munk Knudsen | Chairman | 0 companies |
| Tomas Haagen | Board of Directors | 0 companies |
| Jeppe Theisen | Board of Directors | 0 companies |
| Jesper Brandgaard | Board of Directors | 0 companies |
| Anders Rytter Mikkelsen | Board of Directors | 0 companies |
| Lars Fruergaard Jørgensen | Board of Directors | 0 companies |
| Matt Joseph Regan | Chairman | 0 companies |